相关实验视频

Updated: Sep 16, 2025

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.3K

前列腺动脉栓塞治疗良性前列腺增生:对临床结果的回顾性单中心研究

Jon Bjarnason1, Johann Pall Ingimarsson2, Hjalti Thorisson3

  • 1Department of Radiology, Landspitali University Hospital, Reykjavik, Iceland; Department of Interventional Radiology, Landspitali University Hospital, Reykjavik, Iceland. jonbjarnason92@gmail.com.

Scandinavian journal of urology
|July 10, 2025
PubMed
概括

前列腺动脉栓塞 (PAE) 有效地治疗良性前列腺激增症 (BPH) 症状和尿路保留. 这种安全的手术显著改善了生活质量,并减少了BPH男性的导管依赖.

更多相关视频

Focal Laser Ablation of Prostate Cancer: An Office Procedure11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.0K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.1K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
258
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
227